The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Digital histopathology-based multimodal artificial intelligence scores predict risk of progression in a randomized phase III trial in patients with nonmetastatic castration-resistant prostate cancer.
 
Felix Y Feng
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer
Research Funding - Bayer (Inst); ESSA (Inst); Janssen Oncology (Inst); Lilly (Inst); ORIC Pharmaceuticals (Inst)
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Pooya Mobadersany
Employment - Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development
 
Shaozhou Ken Tian
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Patents, Royalties, Other Intellectual Property - Patent for making cell blocks in cytology.
Travel, Accommodations, Expenses - Janssen Oncology
 
Stephen S. F. Yip
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Joel Greshock
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Najat Khan
Employment - Johnson & Johnson
Leadership - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Johnson & Johnson
Travel, Accommodations, Expenses - Johnson & Johnson
 
Margaret K. Yu
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Sharon McCarthy
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Sabine D. Brookman-May
Employment - Janssen Research & Development
Leadership - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Honoraria - Wellster Healthtech Group
Consulting or Advisory Role - Wellster Healthtech Group
Patents, Royalties, Other Intellectual Property - Founder of Vitruvo eHealth and Developer of a Digital Medicine Application
 
Tamara Todorovic
Employment - Artera
 
Rikiya Yamashita
Employment - Artera
 
Huei-Chung Rebecca Huang
Employment - Artera
 
Timothy N Showalter
Employment - Artera; Flatiron Health
 
Akinori Mitani
Employment - Artera
 
Andre Esteva
Employment - Artera
Leadership - Artera
Stock and Other Ownership Interests - Artera
Patents, Royalties, Other Intellectual Property - Artera's founding IP - multi-modal AI technology for cancer therapy personalization, using digital pathology.
Travel, Accommodations, Expenses - Artera
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen; Johnson and Johnson
Consulting or Advisory Role - Fortis; Janssen Oncology; Teon Therapeutics